Skip to main navigation Skip to search Skip to main content

A PHASE 1 PHARMACOKINETIC, DOSIMETRY, SAFETY, AND DOSE OPTIMIZATION STUDY FOR A SINGLE DOSE OF TLX090-TX (153Sm-DOTMP) TO TREAT METASTATIC BONE PAIN

Project: Research project

Project Details

StatusActive
Effective start/end date2/6/26 → 2/5/30

Funding

  • Telix Pharmaceuticals (Innov) Pty Ltd ( Award # ): $35,100.00